These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 33368414
21. LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production. Han C, Yu G, Mao Y, Song S, Li L, Zhou L, Wang Z, Liu Y, Li M, Xu B. PLoS One; 2020; 15(11):e0240801. PubMed ID: 33137125 [Abstract] [Full Text] [Related]
22. Anaphylatoxin C5a-induced toll-like receptor 4 signaling in bovine neutrophils. Stevens MG, Van Poucke M, Peelman LJ, Rainard P, De Spiegeleer B, Rogiers C, Van de Walle GR, Duchateau L, Burvenich C. J Dairy Sci; 2011 Jan; 94(1):152-64. PubMed ID: 21183027 [Abstract] [Full Text] [Related]
23. Apigenin inhibits C5a-induced proliferation of human nasopharyngeal carcinoma cells through down-regulation of C5aR. Zhang Y, Cao Y, Zhang L, Feng C, Zhou G, Wen G. Biosci Rep; 2018 May 15; 38(3):. PubMed ID: 29685955 [Abstract] [Full Text] [Related]
24. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer. Hao J, Ci X, Xue H, Wu R, Dong X, Choi SYC, He H, Wang Y, Zhang F, Qu S, Zhang F, Haegert AM, Gout PW, Zoubeidi A, Collins C, Gleave ME, Lin D, Wang Y. Eur Urol; 2018 Jun 15; 73(6):949-960. PubMed ID: 29544736 [Abstract] [Full Text] [Related]
25. C5a receptor and interleukin-6 are expressed in tissue macrophages and stimulated keratinocytes but not in pulmonary and intestinal epithelial cells. Fayyazi A, Sandau R, Duong LQ, Götze O, Radzun HJ, Schweyer S, Soruri A, Zwirner J. Am J Pathol; 1999 Feb 15; 154(2):495-501. PubMed ID: 10027407 [Abstract] [Full Text] [Related]
26. Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels. Xu L, Chen X, Shen M, Yang DR, Fang L, Weng G, Tsai Y, Keng PC, Chen Y, Lee SO. Mol Oncol; 2018 Mar 15; 12(3):269-286. PubMed ID: 28865178 [Abstract] [Full Text] [Related]
27. Evidence for a functional role of the second C5a receptor C5L2. Gao H, Neff TA, Guo RF, Speyer CL, Sarma JV, Tomlins S, Man Y, Riedemann NC, Hoesel LM, Younkin E, Zetoune FS, Ward PA. FASEB J; 2005 Jun 15; 19(8):1003-5. PubMed ID: 15784721 [Abstract] [Full Text] [Related]
29. Functional identification of the stable transfection C5aR cell line Molt-4. Zhang C, Xu R, Wang J, Han G, Chen G, Wang R, Wei H, Shen B, Ma Y, Li Y. Cell Mol Immunol; 2007 Dec 15; 4(6):461-5. PubMed ID: 18163958 [Abstract] [Full Text] [Related]
30. PD-L1 is highly expressed in Enzalutamide resistant prostate cancer. Bishop JL, Sio A, Angeles A, Roberts ME, Azad AA, Chi KN, Zoubeidi A. Oncotarget; 2015 Jan 01; 6(1):234-42. PubMed ID: 25428917 [Abstract] [Full Text] [Related]
31. Human colonic epithelial cells detect and respond to C5a via apically expressed C5aR through the ERK pathway. Cao Q, McIsaac SM, Stadnyk AW. Am J Physiol Cell Physiol; 2012 Jun 15; 302(12):C1731-40. PubMed ID: 22496247 [Abstract] [Full Text] [Related]
32. Significant Association of Caveolin-1 and Caveolin-2 with Prostate Cancer Progression. Sugie S, Mukai S, Yamasaki K, Kamibeppu T, Tsukino H, Kamoto T. Cancer Genomics Proteomics; 2015 Jun 15; 12(6):391-6. PubMed ID: 26543085 [Abstract] [Full Text] [Related]
33. Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer. Zhao N, Peacock SO, Lo CH, Heidman LM, Rice MA, Fahrenholtz CD, Greene AM, Magani F, Copello VA, Martinez MJ, Zhang Y, Daaka Y, Lynch CC, Burnstein KL. Sci Transl Med; 2019 Jun 26; 11(498):. PubMed ID: 31243151 [Abstract] [Full Text] [Related]
34. GR silencing impedes the progression of castration-resistant prostate cancer through the JAG1/NOTCH2 pathway via up-regulation of microRNA-143-3p. Zhang L, Jiang H, Zhang Y, Wang C, Xia X, Sun Y. Cancer Biomark; 2020 Jun 26; 28(4):483-497. PubMed ID: 32568179 [Abstract] [Full Text] [Related]
35. C5a receptor-mediated production of IL-8 by the human retinal pigment epithelial cell line, ARPE-19. Fukuoka Y, Medof EM. Curr Eye Res; 2001 Nov 26; 23(5):320-5. PubMed ID: 11910520 [Abstract] [Full Text] [Related]
36. Expression of C5aR (CD88) of synoviocytes isolated from patients with rheumatoid arthritis and osteoarthritis. Yuan G, Wei J, Zhou J, Hu H, Tang Z, Zhang G. Chin Med J (Engl); 2003 Sep 26; 116(9):1408-12. PubMed ID: 14527377 [Abstract] [Full Text] [Related]
37. Overexpression of complement C5a indicates poor survival and therapeutic response in metastatic renal cell carcinoma. Yang C, Yang F, Chen X, Li Y, Hu X, Guo J, Yao J. Int J Biol Markers; 2023 Jun 26; 38(2):124-132. PubMed ID: 36883235 [Abstract] [Full Text] [Related]
38. The human mast cell line HMC-1 expresses C5a receptors and responds to C5a but not to C5a(desArg). Werfel T, Oppermann M, Butterfield JH, Begemann G, Elsner J, Götze O, Zwirner J. Scand J Immunol; 1996 Jul 26; 44(1):30-6. PubMed ID: 8693289 [Abstract] [Full Text] [Related]
39. YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells. Sheng X, Li WB, Wang DL, Chen KH, Cao JJ, Luo Z, He J, Li MC, Liu WJ, Yu C. Mol Med Rep; 2015 Oct 26; 12(4):4867-76. PubMed ID: 26126522 [Abstract] [Full Text] [Related]
40. The Complement Receptor C5aR Controls Acute Inflammation and Astrogliosis following Spinal Cord Injury. Brennan FH, Gordon R, Lao HW, Biggins PJ, Taylor SM, Franklin RJ, Woodruff TM, Ruitenberg MJ. J Neurosci; 2015 Apr 22; 35(16):6517-31. PubMed ID: 25904802 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]